EDGAR Filing Documents for 0001437749-20-010597

Form 8-K - Current report:

SEC Accession No. 0001437749-20-010597

Filing Date

2020-05-13

Accepted

2020-05-13 16:35:47

Documents

Period of Report

2020-05-13

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	dmtp20200513_8k.htm	8-K	30110
2	EXHIBIT 99.1	ex_186480.htm	EX-99.1	168679
3	EXHIBIT 99.2	ex_186481.htm	EX-99.2	41797
4	EXHIBIT 99.3	ex_186482.htm	EX-99.3	15420
5		a01.jpg	GRAPHIC	103301
6		a02.jpg	GRAPHIC	217494
7		a03.jpg	GRAPHIC	156968
8		a04.jpg	GRAPHIC	86619
9		a05.jpg	GRAPHIC	97544
10		a06.jpg	GRAPHIC	108025
11		a07.jpg	GRAPHIC	112484
12		a08.jpg	GRAPHIC	79632
13		a09.jpg	GRAPHIC	83941
14		a10.jpg	GRAPHIC	107652
15		a11.jpg	GRAPHIC	85316
16		a12.jpg	GRAPHIC	123918
17		a13.jpg	GRAPHIC	81848
18		a14.jpg	GRAPHIC	75068
19		a15.jpg	GRAPHIC	66587
20		a16.jpg	GRAPHIC	77926
21		a17.jpg	GRAPHIC	98978
22		a18.jpg	GRAPHIC	89179
23		a19.jpg	GRAPHIC	67717
24		a20.jpg	GRAPHIC	76458
25		a21.jpg	GRAPHIC	97962
26		a22.jpg	GRAPHIC	98021
27		a23.jpg	GRAPHIC	157043
28		a24.jpg	GRAPHIC	89261
29		a25.jpg	GRAPHIC	138839
30		a26.jpg	GRAPHIC	90031
31		image01.jpg	GRAPHIC	14396
	Complete submission text file	0001437749-20-010597.txt		3953689

Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447

Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454

DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)